PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.\', \'Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria.\', \'Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.\', \'Department of Medical Microbiology and Infectious Diseases, Center of Expertise in Mycology, Radboud University Medical Center/Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.\', \'Department of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.\', \'Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University of Cologne, Cologne, Germany.\', \'German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.\', \'Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.\', \'CHU Rennes, Inserm, EHESP, Irset (Institut de recherché en santé, environnement et travail) - UMR_S 1085, Université de Rennes, Rennes, France.\', \'Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/myc.13335
?:hasPublicationType
?:journal
  • Mycoses
is ?:pmid of
?:pmid
?:pmid
  • 34133816
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.069
?:rankingScore_hIndex
  • 59
is ?:relation_isRelatedTo_publication of
?:title
  • ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all